Table 1.
Summary of laboratory results of the patient infected with COVID-19.
| Items | At admission | 1st review | 2nd review | 3rd review | 4th review |
|---|---|---|---|---|---|
| White blood cell count (×109cells/L); (normal range 3.5–9.5) | 10.26 (↑) | 9.11 | 11.59 (↑) | 11.4 (↑) | 15.21 (↑) |
| Neutrophil count (×109cells/L); (normal range 1.8–6.3) | 8.52 (↑) | 7.95 (↑) | 10.11 (↑) | 10.27 (↑) | 13.73 (↑) |
| Neutrophil percentage (%); (normal range 40–75) | 83.1 (↑) | 87.3 (↑) | 87.2 (↑) | 89.9 (↑) | 90.3 (↑) |
| Lymphocyte count (×109 cells/L); (normal range 1.1–3.2) | 1.1 | 0.77 (↓) | 0.68 (↓) | 0.73 (↓) | 0.84 (↓) |
| Lymphocyte percentage (%); (normal range 20–50) | 10.7 (↓) | 8.5 (↓) | 5.8 (↓) | 6.4 (↓) | 5.6 (↓) |
| Eosinophil count (×109cells/L); (normal range 0.02–0.52) | 0 (↓) | 0 (↓) | 0 (↓) | 0 (↓) | 0 (↓) |
| Eosinophil percentage (%); (normal range 0.4–8) | 0 (↓) | 0 (↓) | 0 (↓) | 0 (↓) | 0 (↓) |
| Hemoglobin (g/L); (male normal range 130–175) | 150 | 144 | 144.6 | 117.4 (↓) | 126.7 (↓) |
| Total protein (g/L); (normal range 65–85) | 67.6 | 66.7 | 65.4 | ND | 60.3 (↓) |
| Albumin (g/L); (normal range 40–55) | 39.4 (↓) | 34.6 (↓) | 31.8 (↓) | ND | 29.9 (↓) |
| Globulin (g/L); (normal range 20–30) | 28.2 | 32.1 (↑) | 33.6 (↑) | ND | 30.4 (↑) |
| Albumin/globulin; (normal range 1.5-2.5) | 1.4 (↓) | 1.08 (↓) | 0.95 (↓) | ND | 0.98 (↓) |
| Glucose (mmol/L); (normal range 3.9–6.1) | 20.4 (↑) | 16.18 (↑) | 11.02 (↑) | ND | ND |
| Alanine aminotransferase (U/L); (normal range 9.0–50.0) | 72 (↑) | 46 | 42 | ND | 32 |
| Aspartate aminotransferase (U/L); (normal range 15.0–40.0) | 78 (↑) | 48 (↑) | 45 (↑) | ND | 85 (↑) |
| Creatine Kinase (U/L); (normal range 0.0–171.0) | 1218 (↑) | 158 | ND | ND | ND |
| Creatine Kinase isoenzyme (U/L); (normal range 0.0–25.0) | 38 (↑) | 29m | ND | ND | ND |
| Lactate dehydrogenase (U/L); (normal range 110.0–245.0) | 291 (↑) | 604m | ND | ND | ND |
| Blood urea nitrogen (mmol/L); (normal range 2.8–7.6) | 4.59 | 5.24 | 5.83 | ND | 8.72 (↑) |
| Creatinine (μmol/L); (normal range 64–104) | 107.3 (↑) | 101.2 | 78.3 | ND | 66.4 |
| High-sensitivity C-reactive protein (mg/L); (normal range 0.0–3.0) | 119.76 (↑) | 136.3 (↑) | ND | ND | ND |
| Procalcitonin (ng/ml); (normal range 0.0–0.05) | 1.85 (↑) | 0.39 (↑) | 0.21 (↑) | 0.09 (↑) | 0.20 (↑) |
| Erythrocyte sedimentation rate (mm/h); (male normal range 0–15) | ND | ND | ND | 32 (↑) | ND |
| D-dimer (ng/mL); (normal range 0–500) | 87 | 160 | 477 | 625 (↑) | 993 (↑) |
ND, not detected; (↑), above normal range; (↓) below normal range. At admisssion, January 9; 1st review, around January 12; 2nd review, around January 14; 3rd review, around January 17; 4th review around January 19.